Correlation Between Boston Scientific and Novacyt SA
Can any of the company-specific risk be diversified away by investing in both Boston Scientific and Novacyt SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boston Scientific and Novacyt SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Boston Scientific Corp and Novacyt SA, you can compare the effects of market volatilities on Boston Scientific and Novacyt SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boston Scientific with a short position of Novacyt SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boston Scientific and Novacyt SA.
Diversification Opportunities for Boston Scientific and Novacyt SA
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Boston and Novacyt is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Boston Scientific Corp and Novacyt SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt SA and Boston Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boston Scientific Corp are associated (or correlated) with Novacyt SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt SA has no effect on the direction of Boston Scientific i.e., Boston Scientific and Novacyt SA go up and down completely randomly.
Pair Corralation between Boston Scientific and Novacyt SA
Considering the 90-day investment horizon Boston Scientific is expected to generate 1.31 times less return on investment than Novacyt SA. But when comparing it to its historical volatility, Boston Scientific Corp is 6.12 times less risky than Novacyt SA. It trades about 0.12 of its potential returns per unit of risk. Novacyt SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 82.00 in Novacyt SA on September 19, 2024 and sell it today you would lose (12.00) from holding Novacyt SA or give up 14.63% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Boston Scientific Corp vs. Novacyt SA
Performance |
Timeline |
Boston Scientific Corp |
Novacyt SA |
Boston Scientific and Novacyt SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Boston Scientific and Novacyt SA
The main advantage of trading using opposite Boston Scientific and Novacyt SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boston Scientific position performs unexpectedly, Novacyt SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt SA will offset losses from the drop in Novacyt SA's long position.Boston Scientific vs. Stryker | Boston Scientific vs. Abbott Laboratories | Boston Scientific vs. Medtronic PLC | Boston Scientific vs. DexCom Inc |
Novacyt SA vs. Aethlon Medical | Novacyt SA vs. Bone Biologics Corp | Novacyt SA vs. Tivic Health Systems | Novacyt SA vs. Cytosorbents Crp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |